NatureCell

Beta

KRX Filings & Disclosures 2026

Risk Factors

• • Overseas raw material imports expose currency risk; no quantified KRW impact disclosed
• • No derivative transactions currently outstanding; no past derivative activity reported

Management Discussion & Analysis

• • Revenue KRW 20.7B (-35.8% YoY), Operating loss KRW 3.6B vs. operating profit KRW 59M prior year
• • Stem cell segment revenue KRW 11.9B, operating loss KRW 2.4B; decline due to culture media system upgrade and schedule adjustment

Business Overview

• • Stem cell business 57% and food business 41% share of KRW 20.7B revenue in FY2025
• • JointStem osteoarthritis treatment received US FDA Breakthrough Therapy designation Mar 2025 and Expanded Access Program approval Jun 2025

What are the latest NatureCell DART filings in 2026?

NatureCell (KRX code 007390) has filed an annual report on March 23, 2026 with DART. SignalX tracks every new DART disclosure with AI-powered English summaries of business overview, risk factors, and management discussion.

When did NatureCell file its most recent annual report?

NatureCell filed its most recent annual report on March 23, 2026. The annual report includes audited financial statements, business overview, risk factors, and management discussion (MD&A), all available on SignalX with AI-generated English summaries and KIFRS financial data.

What is NatureCell's KRX stock code?

NatureCell's KRX stock code is 007390. The 6-digit stock code is the KRX standard identifier for every listed security. You can use stock code 007390 to look up all NatureCell disclosures on DART, or browse them here on SignalX with AI-powered English analysis.

How often does NatureCell file with DART?

Korean listed companies file an annual report once per year (typically within 90 days of fiscal year-end), a half-year report once mid-year, and quarterly reports for Q1 and Q3 — three regular periodic disclosures plus the annual. Material event reports are filed as needed when corporate events occur. SignalX monitors DART daily.

What is the difference between annual, half-year, and quarterly reports in Korea?

An annual report is a comprehensive filing with audited financials, business overview, and risk factors — analogous to the US 10-K. A half-year (interim) report covers H1 results. Quarterly reports cover Q1 or Q3 — analogous to the US 10-Q but Korea publishes only two quarterly reports per year (with the half-year report covering Q2). SignalX provides AI-generated English summaries for all three filing types for NatureCell.

Where can I find NatureCell financial data and KIFRS metrics?

SignalX extracts KIFRS consolidated financial data from NatureCell annual reports, including revenue, gross profit, operating income, net income, total assets, stockholders' equity, EPS (basic/diluted), operating cash flow, and capital expenditure — all in KRW. Multi-year financial trends are displayed in the Financial Summary table above.